Biomea FusionBMEA +6.50%31 PB Ratio is 5.06 as of Jun. 26, 2026. GuruFocus rates BMEA with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 1,232 Biotechnology companies, Biomea Fusion ranks worse than 69.48% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Biomea Fusion's share price is $1.31. Biomea Fusion's Book Value per Share for the quarter that ended in Mar. 2026 was $0.26. Hence, Biomea Fusion's PB Ratio of today is 5.06.
The historical rank and industry rank for Biomea Fusion's PB Ratio or its related term are showing as below:
BMEA'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 5.12
Current: 5.04
During the past 7 years, Biomea Fusion's highest PB Ratio was 5.12. The lowest was 0.00. And the median was 0.00.
BMEA's PB Ratio is ranked worse than 69.48% of 1232
companies
in the Biotechnology industry
Industry Median: 2.8
vs BMEA: 5.04
During the past 12 months, Biomea Fusion's average Book Value Per Share Growth Rate was -71.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -51.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -0.90% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Biomea Fusion was 191.70% per year. The lowest was -51.90% per year. And the median was -38.60% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Biomea Fusion PB Ratio Related Terms
Biomea Fusion PB Ratio Historical Data
* Premium members only.
The historical data trend for Biomea Fusion's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Biomea Fusion's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biomea Fusion PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Biomea Fusion's PB Ratio distribution charts can be found below:
* The bar in red indicates where Biomea Fusion's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Biomea Fusion's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Biomea Fusion (BMEA) has a PB Ratio of 5.06 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Biomea Fusion and its competitors. According to the industry distribution chart, Biomea Fusion ranks #856 out of 1232 companies in the Biotechnology industry, placing it in the top 69.5%.
Is Biomea Fusion's PB Ratio too high?
Biomea Fusion's current PB Ratio is 5.06. The Biotechnology industry median PB Ratio is 2.80. Biomea Fusion's value of 5.06 is 80.7% above this industry median. Based on the distribution chart, Biomea Fusion ranks #856 out of 1232 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Biomea Fusion has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Biomea Fusion's PB Ratio compare to VRCA and PMN?
According to the Biotechnology industry distribution chart, Biomea Fusion ranks #856 out of 1232 companies for PB Ratio. This places Biomea Fusion in the lower half of its industry. The industry median PB Ratio is 2.80. Biomea Fusion's value of 5.06 is 80.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.80, based on 1,232 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biomea Fusion's current PB Ratio of 5.06 is 80.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Biomea Fusion and its competitors. For the Biotechnology industry, the median PB Ratio is 2.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biomea Fusion's current PB Ratio is 5.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomea Fusion stock overvalued right now?
Biomea Fusion (BMEA) has a current PB Ratio of 5.06. The current PB Ratio is 5.06 and 80.7% above the Biotechnology industry median of 2.80. Biomea Fusion's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Biomea Fusion (BMEA), the current PB Ratio is 5.06 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.
31GF Score
Get the complete analysis for BMEA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMEA has been successfully added to your 
